MedPath

A randomized phase II study to evaluate the prolonged prophylactic antibacterial drug treatment for patients with elevated drain-amylase concentration after gastrectomy with D2 lymph node dissectio

Not Applicable
Conditions
Gastric Cancer
Registration Number
JPRN-UMIN000012152
Lead Sponsor
Shizuoka Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Having other active infectious disease 2) combined resection (gall bladder and spleen are exceptions) 3) Possibly pregnant, or breast feeding woman 4) with psychiatric disorder 5) Receiving steroids 6) With Acute myocardial infaction in 6 months or with unstable ungina 7) With uncontrolled hypertention 8) With uncontrolled diabetes mellitus 9) With pulmonary disease and require continuous oxygen therapy 10) With allergy to cephalosporin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of post-operative intra-abdominal infectious complications (anastomotic leakage, pancreas related infection, and intra-abdominal abscess)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath